<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>HLA-DR–expressing fibroblast-like synoviocytes are inducible antigen presenting cells that present autoantigens in Lyme arthritis</dc:title><dc:creator>Rouse,	Joseph R.	(Avtor)
	</dc:creator><dc:creator>Danner,	Rebecca	(Avtor)
	</dc:creator><dc:creator>Wahhab,	Amanda	(Avtor)
	</dc:creator><dc:creator>Pereckas,	Michaela	(Avtor)
	</dc:creator><dc:creator>Nguyen,	Christine	(Avtor)
	</dc:creator><dc:creator>McClune,	Mecaila E.	(Avtor)
	</dc:creator><dc:creator>Steere,	Allen C.	(Avtor)
	</dc:creator><dc:creator>Strle,	Klemen	(Avtor)
	</dc:creator><dc:creator>Jutras,	Brandon L.	(Avtor)
	</dc:creator><dc:creator>Lochhead,	Robert B.	(Avtor)
	</dc:creator><dc:subject>Lyme arthritis</dc:subject><dc:subject>autoimmune diseases</dc:subject><dc:subject>infectious disease</dc:subject><dc:description>Objective: HLA-DR–expressing fibroblast-like synoviocytes (FLS) are a prominent cell type in synovial tissue in chronic inflammatory forms of arthritis. FLS-derived extracellular matrix (ECM) proteins, including fibronectin-1 (FN1), contain immunogenic CD4+ T cell epitopes in patients with postinfectious Lyme arthritis (LA). However, the role of FLS in presentation of these T cell epitopes remains uncertain. Methods: Primary LA FLS and primary murine FLS stimulated with interferon gamma (IFNγ), Borrelia burgdorferi, and/or B burgdorferi peptidoglycan (PG) were assessed for properties associated with antigen presentation. HLA-DR–presented peptides from stimulated LA FLS were identified by immunopeptidomics analysis. OT-II T cells were co-cultured with stimulated murine FLS in the presence of cognate ovalbumin antigen to determine the potential of FLS to act as inducible antigen presenting cells (APCs). Results: FLS expressed HLA-DR molecules within inflamed synovial tissue and tendons from patients with postinfectious LA in situ. Major histocompatibility complex (MHC) class II and co-stimulatory molecules were expressed by FLS following in vitro stimulation with IFNγ and B burgdorferi and presented both foreign and self-MHC-II peptides, including an immunogenic T cell epitope derived from Lyme autoantigen FN1. Stimulated FLS induced proliferation of naive OT-II CD4+ T cells that were dependent on OT-II antigen and CD40. Stimulation with B burgdorferi PG enhanced FLS-mediated T cell activation. Conclusion: MHC-II+ FLS are inducible APCs that can induce CD4+ T cell activation in an antigen- and CD40-dependent manner. Activated FLS can also present ECM-derived Lyme autoantigens, implicating FLS in amplifying tissue-localized autoimmunity in LA.</dc:description><dc:date>2024</dc:date><dc:date>2026-06-02 09:46:45</dc:date><dc:type>Neznano</dc:type><dc:identifier>29643</dc:identifier><dc:identifier>UDK: 616.9</dc:identifier><dc:identifier>ISSN pri članku: 2578-5745</dc:identifier><dc:identifier>DOI: 10.1002/acr2.11710</dc:identifier><dc:identifier>COBISS_ID: 279250691</dc:identifier><dc:language>sl</dc:language></metadata>
